Dec. 15, 2017 – The FDA announced this week that it has finalized its guidance document covering how industry should treat product name placement, size and prominence in promotional labeling and ads, largely keeping intact the draft guidance document it issued on the matter in 2013, and reiterating the agency’s position that “the disclosure of […]
Read more